Characterization and Inhibition of Human Hexokinase Domain Containing Protein 1 Reveals an Enzyme with Unique Catalytic and Regulatory Traits
- 4 November 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 20 (11) , 2779-2786
Abstract
Hexokinase domain containing protein 1 (HKDC1) is a recently discovered fifth human hexokinase isozyme that is significantly upregulated in several disease states, including lung and liver cancers. Cellular studies suggest that HKDC1 is a low activity hexokinase; however, its functional characteristics have remained enigmatic. Here, we describe the kinetic and regulatory features of recombinant human HKDC1, demonstrating it to be a robust hexokinase (kcat/Km,glucose = 1.5 × 104 M-1 s-1) with a unique glucose Km value (0.49 ± 0.07 mM) that differs markedly from all other human hexokinase isozymes. The isolated C-terminal domain of HKDC1 displays kinetic characteristics nearly identical to the full-length enzyme, whereas the N-terminal domain is inactive. Unlike all other 100 kDa vertebrate hexokinases characterized to date, HKDC1 is insensitive to product inhibition by physiological concentrations of glucose 6-phosphate, with apparent inhibition constants above 1 mM. The hexokinase activity of HKDC1 is also insensitive to Dinaciclib, a pan cyclin-dependent kinase inhibitor that reportedly disrupts the ability of nuclear localized HKDC1 to phosphorylate retinoblastoma-binding protein 5. Conversely, the hexokinase activity of HKDC1 is potently inhibited by a synthetic glucosamine derivative previously developed for hexokinase 1 and 2, with an IC50 value of 103 ± 6 nM. An HKDC1 variant associated with retinitis pigmentosa, T58M, displays a modest, but statistically significant 2-fold decrease in catalytic efficiency (kcat/Km,glucose) compared to the wild-type enzyme. Together, our results provide a detailed functional characterization of recombinant HKDC1 and set the stage for investigating the link between HKDC1 catalysis and human disease.Keywords
Funding Information
- U.S. Department of Health and Human Services (125926, 133843)
- Florida State University (47082)
- Werner Herz Endowment
- Pfeiffer Professorship for Cancer Research
This publication has 43 references indexed in Scilit:
- Identification of residues mediating homotropic regulation in human hexokinase 3 reveals a common allosteric interface shared with hexokinase 1Archives of Biochemistry and Biophysics, 2025
- Nuclear-localized HKDC1 promotes hepatocellular carcinoma through phosphorylating RBBP5 to upregulate H3K4me3Cell Reports, 2025
- HKDC1 reprograms lipid metabolism to enhance gastric cancer metastasis and cisplatin resistance via forming a ribonucleoprotein complexCancer Letters, 2023
- Oxidative stress-induced alterations in retinal glucose metabolism in Retinitis PigmentosaFree Radical Biology and Medicine, 2022
- High expression of hexokinase domain containing 1 is associated with poor prognosis and aggressive phenotype in hepatocarcinomaBiochemical and Biophysical Research Communications, 2016
- Role of connecting loop I in catalysis and allosteric regulation of human glucokinaseProtein Science, 2014
- Molecular evolution of the vertebrate hexokinase gene family: Identification of a conserved fifth vertebrate hexokinase geneComparative Biochemistry and Physiology Part D: Genomics and Proteomics, 2008
- Crystal structures of mutant monomeric hexokinase I reveal multiple ADP binding sites and conformational changes relevant to allosteric regulation 1 1Edited by P. E. WrightJournal of Molecular Biology, 2000
- Hexokinases1995
- Rat brain hexokinase: Location of the allosteric regulatory site in a structural domain at the N-terminus of the enzymeArchives of Biochemistry and Biophysics, 1987